Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,772.00
-10.00 (-0.56%)
Apr 17, 2026, 3:30 PM JST
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of 573.22 billion as of April 17, 2026. Its market cap has increased by 16.49% in one year.
Market Cap
573.22B
Enterprise Value
510.73B
Revenue
287.99B
Ranking
n/a
PE Ratio
19.40
Stock Price
1,772.00
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 150.82B to 573.22B, an increase of 280.07%. That is a compound annual growth rate of 3.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 573.22B | 16.80% |
| Dec 30, 2025 | 490.75B | -11.17% |
| Dec 30, 2024 | 552.48B | 8.00% |
| Dec 29, 2023 | 511.57B | 23.49% |
| Dec 30, 2022 | 414.25B | -26.39% |
| Dec 30, 2021 | 562.77B | -15.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 14.02T |
| Otsuka Holdings | 5.51T |
| Daiichi Sankyo Company | 5.19T |
| Astellas Pharma | 4.67T |
| Kyowa Kirin | 1.31T |
| Ono Pharmaceutical | 1.15T |
| JCR Pharmaceuticals | 69.41B |
| Perseus Proteomics | 3.55B |